Skip to Main Content

Author Details

Allan Zimet
Epworth Hospital
1988
23
11
PMIDPaper TitleJournal TitlePublished Year
33870631Patient demographics and management landscape of metastatic colorectal cancer in the third-line setting: Real-world data in an australian population.Asia Pac J Clin Oncol2022
33026266Pralatrexate in relapsed/refractory T-cell lymphoma: a retrospective multicenter study.Leuk Lymphoma2021
34483054A decision support tool for the detection of pancreatic cancer in general practice: A modified Delphi consensus.Pancreatology2021
30230679Chemotherapy and biologic use in the routine management of metastatic colorectal cancer in Australia: is clinical practice following the evidence?Intern Med J2019
29958812Previous Bevacizumab and Efficacy of Later Anti-Epidermal Growth Factor Receptor Antibodies in Metastatic Colorectal Cancer: Results From a Large International Registry.Clin Colorectal Cancer2018
26968236Impact of Primary Tumor Site on Bevacizumab Efficacy in Metastatic Colorectal Cancer.Clin Colorectal Cancer2016
24575793Multicenter randomized, open-label phase II trial of sequential erlotinib and gemcitabine compared with gemcitabine monotherapy as first-line therapy in elderly or ECOG PS two patients with advanced NSCLC.Asia Pac J Clin Oncol2015
25871458Novel quality indicators for metastatic colorectal cancer management identify significant variations in these measures across treatment centers in Australia.Asia Pac J Clin Oncol2015
24403265Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.Cancer Med2013
16019490Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia.Leuk Lymphoma2005
11313694Severe interstitial pneumonitis following high-dose cyclophosphamide, thiotepa and docetaxel: two case reports and a review of the literature.Bone Marrow Transplant2001
10652412Use of [F]-fluorodeoxyglucose positron emission tomography in monitoring response of recurrent neurotropic desmoplastic melanoma to radiotherapy.Otolaryngol Head Neck Surg2000
9586914Phase II study of docetaxel and cisplatin in advanced non-small-cell lung cancer.J Clin Oncol1998
9053501Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.J Clin Oncol1997
8673348Patients' beliefs about cancer management.Support Care Cancer1996
7847260A phase II trial of zeniplatin in metastatic melanoma.Am J Clin Oncol1995
7919453Lean body mass, body surface area and epirubicin kinetics.Anticancer Drugs1994
7999404A phase I/II study of the intralesional injection of ricin-monoclonal antibody conjugates in patients with hepatic metastases.Eur J Cancer1994
8483200Oral methotrexate for superficial transitional cell carcinoma of the bladder.J Urol1993
1449114A phase II study of cisplatinum and continuous infusion 5-fluorouracil for metastatic melanoma.Am J Clin Oncol1992
1524039A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.Am J Clin Oncol1992
1688462Medical education in palliative care.Med J Aust1990
2832115Flare responses in small cell carcinoma of the lung.Clin Nucl Med1988
  • 1 - 23 of 23

Recommended Authors

Franciscus Gasthuis & Vlietland Hospital Rotterdam and Schiedam
Career Start Year 2006
Number of shared co-authors 1
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 1
Washington University School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Karmanos Cancer Center, Wayne State University
Career Start Year 1999
Number of shared co-authors 0
Brody School of Medicine, East Carolina University
Career Start Year 1997
Number of shared co-authors 1
University of California Davis Comprehensive Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 1
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1994
Number of shared co-authors 1
USC Norris Comprehensive Cancer Center
Career Start Year 1993
Number of shared co-authors 0
Schulich School of Medicine and Dentistry, University of Western Ontario
Career Start Year 1993
Number of shared co-authors 3
Mayo Clinic
Career Start Year 1993
Number of shared co-authors 0
Odette Cancer Centre
Career Start Year 1991
Number of shared co-authors 1
Lehigh Valley Topper Cancer Institute
Career Start Year 1990
Number of shared co-authors 1
Institut Curie
Career Start Year 1990
Number of shared co-authors 0
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1987
Number of shared co-authors 0
Leeds Teaching Hospitals NHS Trust, University of Leeds
Career Start Year 1986
Number of shared co-authors 1
Westmead Clinical School, University of Sydney
Career Start Year 1986
Number of shared co-authors 0
Rogel Comprehensive Cancer Center, University of Michigan ann arbor
Career Start Year 1985
Number of shared co-authors 0
University of Bern
Career Start Year 1985
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1984
Number of shared co-authors 0
Northwestern University Feinberg School of Medicine
Career Start Year 1984
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 1
Siteman Cancer Center, Washington University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
Meyer Cancer Center
Career Start Year 1981
Number of shared co-authors 1
Meyer Cancer Center, Englander Institute for Precision Medicine
Career Start Year 1978
Number of shared co-authors 0
University Health Network, Princess Margaret Cancer Centre
Career Start Year 1977
Number of shared co-authors 7
National Cancer Institute, National Institutes of Health
Career Start Year 1974
Number of shared co-authors 0
NSABP Foundation
Career Start Year 1972
Number of shared co-authors 0
Erasmus MC Cancer Institute
Career Start Year 1972
Number of shared co-authors 1

Collaborators

Austin & Repatriation Medical Centre
Co-authored papers 2
Olivia Newton-John Cancer Wellness and Research Centre
Co-authored papers 2
Olivia Newton-John Cancer Research Institute
Co-authored papers 1
Peter MacCallum Cancer Centre, University of Melbourne
Co-authored papers 1
University of Wollongong
Co-authored papers 1
Ontario Institute for Cancer Research
Co-authored papers 1
Co-authored papers 1
Maastricht University
Co-authored papers 1
University of California los angeles
Co-authored papers 1
The University of Melbourne
Co-authored papers 1
Peter MacCallum Cancer Centre
Co-authored papers 1
Peter MacCallum Cancer Centre
Co-authored papers 1